Document is current

Any future updates will be listed below

Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancer

Crossref DOI link: https://doi.org/10.1038/s41523-026-00901-8

Published Online: 2026-02-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark